APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Opioid Induced Side Effects Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Opioid Induced Side Effects Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17401933032 January 2026184 pages

Choose your research edition.

Industry ResearchOpioid Induced Side Effects Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Induced Side Effects Treatment Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Opioid Induced Side Effects Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Induced Side Effects Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Induced Side Effects Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Opioid Induced Side Effects Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Opioid Induced Side Effects Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Opioid Induced Side Effects Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Induced Side Effects Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Opioid Induced Side Effects Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Opioid Induced Side Effects Treatment include AstraZeneca, SLA Pharma, Shionogi, Progenics Pharmaceuticals, Cubist Pharmaceuticals and AIKO Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Opioid Induced Side Effects Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Opioid Induced Side Effects Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Opioid Induced Side Effects Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Opioid Induced Side Effects Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Opioid Induced Side Effects Treatment Segment by Company

AstraZeneca

SLA Pharma

Shionogi

Progenics Pharmaceuticals

Cubist Pharmaceuticals

AIKO Biotechnology

Opioid Induced Side Effects Treatment Segment by Type

Risperidone

Methylphenidate

Cetirizine

Other

Opioid Induced Side Effects Treatment Segment by Application

Drug Overdose Treatment

Pain Treatment

Other

Opioid Induced Side Effects Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Induced Side Effects Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Induced Side Effects Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Induced Side Effects Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Opioid Induced Side Effects Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioid Induced Side Effects Treatment industry.

Chapter 3: Detailed analysis of Opioid Induced Side Effects Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Induced Side Effects Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Risperidone Table 3. Key Players of Methylphenidate Table 4. Key Players of Cetirizine Table 3. Key Players of Other Table 4. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Drug Overdose Treatment Table 6. Key Players of Pain Treatment Table 7. Key Players of Other Table 8. Global Opioid Induced Side Effects Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Opioid Induced Side Effects Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Opioid Induced Side Effects Treatment Market Share by Region (2021-2026) Table 11. Global Opioid Induced Side Effects Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Opioid Induced Side Effects Treatment Market Share by Region (2027-2032) Table 13. Opioid Induced Side Effects Treatment Industry Trends Table 14. Opioid Induced Side Effects Treatment Industry Drivers Table 15. Opioid Induced Side Effects Treatment Industry Opportunities and Challenges Table 16. Opioid Induced Side Effects Treatment Industry Restraints Table 17. Global Opioid Induced Side Effects Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Opioid Induced Side Effects Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Opioid Induced Side Effects Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Opioid Induced Side Effects Treatment Key Company Head Office and Area Served Table 21. Global Opioid Induced Side Effects Treatment Company, Product Type & Application Table 22. Global Opioid Induced Side Effects Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Opioid Induced Side Effects Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Opioid Induced Side Effects Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Opioid Induced Side Effects Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Opioid Induced Side Effects Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Opioid Induced Side Effects Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Opioid Induced Side Effects Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Opioid Induced Side Effects Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Opioid Induced Side Effects Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Opioid Induced Side Effects Treatment Revenue Market Share by Application (2027-2032) Table 35. AstraZeneca Company Information Table 36. AstraZeneca Business Overview Table 37. AstraZeneca Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. AstraZeneca Opioid Induced Side Effects Treatment Product Portfolio Table 39. AstraZeneca Recent Development Table 40. SLA Pharma Company Information Table 41. SLA Pharma Business Overview Table 42. SLA Pharma Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. SLA Pharma Opioid Induced Side Effects Treatment Product Portfolio Table 44. SLA Pharma Recent Development Table 45. Shionogi Company Information Table 46. Shionogi Business Overview Table 47. Shionogi Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Shionogi Opioid Induced Side Effects Treatment Product Portfolio Table 49. Shionogi Recent Development Table 50. Progenics Pharmaceuticals Company Information Table 51. Progenics Pharmaceuticals Business Overview Table 52. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product Portfolio Table 54. Progenics Pharmaceuticals Recent Development Table 55. Cubist Pharmaceuticals Company Information Table 56. Cubist Pharmaceuticals Business Overview Table 57. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product Portfolio Table 59. Cubist Pharmaceuticals Recent Development Table 60. AIKO Biotechnology Company Information Table 61. AIKO Biotechnology Business Overview Table 62. AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. AIKO Biotechnology Opioid Induced Side Effects Treatment Product Portfolio Table 64. AIKO Biotechnology Recent Development Table 65. North America Opioid Induced Side Effects Treatment Market Size by Type (2021-2026) & (US$ Million) Table 66. North America Opioid Induced Side Effects Treatment Market Size by Type (2027-2032) & (US$ Million) Table 67. North America Opioid Induced Side Effects Treatment Market Size by Application (2021-2026) & (US$ Million) Table 68. North America Opioid Induced Side Effects Treatment Market Size by Application (2027-2032) & (US$ Million) Table 69. North America Opioid Induced Side Effects Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America Opioid Induced Side Effects Treatment Market Size by Country (2021-2026) Table 71. North America Opioid Induced Side Effects Treatment Market Size by Country (2027-2032) Table 72. Europe Opioid Induced Side Effects Treatment Market Size by Type (2021-2026) & (US$ Million) Table 73. Europe Opioid Induced Side Effects Treatment Market Size by Type (2027-2032) & (US$ Million) Table 74. Europe Opioid Induced Side Effects Treatment Market Size by Application (2021-2026) & (US$ Million) Table 75. Europe Opioid Induced Side Effects Treatment Market Size by Application (2027-2032) & (US$ Million) Table 76. Europe Opioid Induced Side Effects Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe Opioid Induced Side Effects Treatment Market Size by Country (2021-2026) Table 78. Europe Opioid Induced Side Effects Treatment Market Size by Country (2027-2032) Table 79. China Opioid Induced Side Effects Treatment Market Size by Type (2021-2026) & (US$ Million) Table 80. China Opioid Induced Side Effects Treatment Market Size by Type (2027-2032) & (US$ Million) Table 81. China Opioid Induced Side Effects Treatment Market Size by Application (2021-2026) & (US$ Million) Table 82. China Opioid Induced Side Effects Treatment Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Opioid Induced Side Effects Treatment Market Size by Type (2021-2026) & (US$ Million) Table 84. Asia Opioid Induced Side Effects Treatment Market Size by Type (2027-2032) & (US$ Million) Table 85. Asia Opioid Induced Side Effects Treatment Market Size by Application (2021-2026) & (US$ Million) Table 86. Asia Opioid Induced Side Effects Treatment Market Size by Application (2027-2032) & (US$ Million) Table 87. Asia Opioid Induced Side Effects Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia Opioid Induced Side Effects Treatment Market Size by Country (2021-2026) Table 89. Asia Opioid Induced Side Effects Treatment Market Size by Country (2027-2032) Table 90. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2021-2026) & (US$ Million) Table 91. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2027-2032) & (US$ Million) Table 92. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2021-2026) & (US$ Million) Table 93. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2027-2032) & (US$ Million) Table 94. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2021-2026) Table 96. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Opioid Induced Side Effects Treatment Product Image Figure 2. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Opioid Induced Side Effects Treatment Market Share by Type: 2025 VS 2032 Figure 4. Risperidone Image Figure 5. Methylphenidate Image Figure 6. Cetirizine Image Figure 7. Other Image Figure 8. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Opioid Induced Side Effects Treatment Market Share by Application: 2025 VS 2032 Figure 10. Drug Overdose Treatment Image Figure 11. Pain Treatment Image Figure 12. Other Image Figure 13. Global Opioid Induced Side Effects Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 15. Global Opioid Induced Side Effects Treatment Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Opioid Induced Side Effects Treatment Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Opioid Induced Side Effects Treatment Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Opioid Induced Side Effects Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Opioid Induced Side Effects Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Opioid Induced Side Effects Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 25. North America Opioid Induced Side Effects Treatment Market Share by Type (2021-2032) Figure 26. North America Opioid Induced Side Effects Treatment Market Share by Application (2021-2032) Figure 27. North America Opioid Induced Side Effects Treatment Market Share by Country (2021-2032) Figure 28. United States Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Canada Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Opioid Induced Side Effects Treatment Market Share by Type (2021-2032) Figure 33. Europe Opioid Induced Side Effects Treatment Market Share by Application (2021-2032) Figure 34. Europe Opioid Induced Side Effects Treatment Market Share by Country (2021-2032) Figure 35. Germany Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 36. France Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Italy Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Russia Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Opioid Induced Side Effects Treatment Market Share by Type (2021-2032) Figure 43. China Opioid Induced Side Effects Treatment Market Share by Application (2021-2032) Figure 44. Asia Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 45. Asia Opioid Induced Side Effects Treatment Market Share by Type (2021-2032) Figure 46. Asia Opioid Induced Side Effects Treatment Market Share by Application (2021-2032) Figure 47. Asia Opioid Induced Side Effects Treatment Market Share by Country (2021-2032) Figure 48. Japan Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 52. India Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Australia Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Country (2021-2032) Figure 58. Brazil Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 63. UAE Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Chile Opioid Induced Side Effects Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Risperidone
  • Methylphenidate
  • Cetirizine
  • Other
Applications
  • Drug Overdose Treatment
  • Pain Treatment
  • Other
Companies covered
  • AstraZeneca
  • SLA Pharma
  • Shionogi
  • Progenics Pharmaceuticals
  • Cubist Pharmaceuticals
  • AIKO Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Risperidone
  5. 1.2.3 Methylphenidate
  6. 1.2.4 Cetirizine
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Drug Overdose Treatment
  11. 1.3.3 Pain Treatment
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Opioid Induced Side Effects Treatment Growth Trends by Region
  15. 1.5.1 Global Opioid Induced Side Effects Treatment Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Opioid Induced Side Effects Treatment Market Size by Region (2021-2026)
  17. 1.5.3 Opioid Induced Side Effects Treatment Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Opioid Induced Side Effects Treatment Market Dynamics
  1. 2.1 Opioid Induced Side Effects Treatment Industry Trends
  2. 2.2 Opioid Induced Side Effects Treatment Industry Drivers
  3. 2.3 Opioid Induced Side Effects Treatment Industry Opportunities and Challenges
  4. 2.4 Opioid Induced Side Effects Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Opioid Induced Side Effects Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Opioid Induced Side Effects Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Opioid Induced Side Effects Treatment Key Company Head office and Area Served
  4. 3.4 Global Opioid Induced Side Effects Treatment Company, Product Type & Application
  5. 3.5 Global Opioid Induced Side Effects Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Opioid Induced Side Effects Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Opioid Induced Side Effects Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Opioid Induced Side Effects Treatment Tier 1, Tier 2, and Tier 3
4 Opioid Induced Side Effects Treatment Market by Type
  1. 4.1 Global Opioid Induced Side Effects Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Opioid Induced Side Effects Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Opioid Induced Side Effects Treatment Market Size Share by Type (2021-2032)
5 Opioid Induced Side Effects Treatment Market by Application
  1. 5.1 Global Opioid Induced Side Effects Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Opioid Induced Side Effects Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Opioid Induced Side Effects Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AstraZeneca Opioid Induced Side Effects Treatment Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 SLA Pharma
  8. 6.2.1 SLA Pharma Company Information
  9. 6.2.2 SLA Pharma Business Overview
  10. 6.2.3 SLA Pharma Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 SLA Pharma Opioid Induced Side Effects Treatment Product Portfolio
  12. 6.2.5 SLA Pharma Recent Developments
  13. 6.3 Shionogi
  14. 6.3.1 Shionogi Company Information
  15. 6.3.2 Shionogi Business Overview
  16. 6.3.3 Shionogi Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Shionogi Opioid Induced Side Effects Treatment Product Portfolio
  18. 6.3.5 Shionogi Recent Developments
  19. 6.4 Progenics Pharmaceuticals
  20. 6.4.1 Progenics Pharmaceuticals Company Information
  21. 6.4.2 Progenics Pharmaceuticals Business Overview
  22. 6.4.3 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product Portfolio
  24. 6.4.5 Progenics Pharmaceuticals Recent Developments
  25. 6.5 Cubist Pharmaceuticals
  26. 6.5.1 Cubist Pharmaceuticals Company Information
  27. 6.5.2 Cubist Pharmaceuticals Business Overview
  28. 6.5.3 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product Portfolio
  30. 6.5.5 Cubist Pharmaceuticals Recent Developments
  31. 6.6 AIKO Biotechnology
  32. 6.6.1 AIKO Biotechnology Company Information
  33. 6.6.2 AIKO Biotechnology Business Overview
  34. 6.6.3 AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AIKO Biotechnology Opioid Induced Side Effects Treatment Product Portfolio
  36. 6.6.5 AIKO Biotechnology Recent Developments
7 North America
  1. 7.1 North America Opioid Induced Side Effects Treatment Market Size (2021-2032)
  2. 7.2 North America Opioid Induced Side Effects Treatment Market Size by Type
  3. 7.2.1 North America Opioid Induced Side Effects Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Opioid Induced Side Effects Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Opioid Induced Side Effects Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Opioid Induced Side Effects Treatment Market Size by Application
  7. 7.3.1 North America Opioid Induced Side Effects Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Opioid Induced Side Effects Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Opioid Induced Side Effects Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Opioid Induced Side Effects Treatment Market Size by Country
  11. 7.4.1 North America Opioid Induced Side Effects Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Opioid Induced Side Effects Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Opioid Induced Side Effects Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Opioid Induced Side Effects Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Opioid Induced Side Effects Treatment Market Size (2021-2032)
  2. 8.2 Europe Opioid Induced Side Effects Treatment Market Size by Type
  3. 8.2.1 Europe Opioid Induced Side Effects Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Opioid Induced Side Effects Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Opioid Induced Side Effects Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Opioid Induced Side Effects Treatment Market Size by Application
  7. 8.3.1 Europe Opioid Induced Side Effects Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Opioid Induced Side Effects Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Opioid Induced Side Effects Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Opioid Induced Side Effects Treatment Market Size by Country
  11. 8.4.1 Europe Opioid Induced Side Effects Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Opioid Induced Side Effects Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Opioid Induced Side Effects Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Opioid Induced Side Effects Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Opioid Induced Side Effects Treatment Market Size (2021-2032)
  2. 9.2 China Opioid Induced Side Effects Treatment Market Size by Type
  3. 9.2.1 China Opioid Induced Side Effects Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Opioid Induced Side Effects Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Opioid Induced Side Effects Treatment Market Share by Type (2021-2032)
  6. 9.3 China Opioid Induced Side Effects Treatment Market Size by Application
  7. 9.3.1 China Opioid Induced Side Effects Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Opioid Induced Side Effects Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Opioid Induced Side Effects Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Opioid Induced Side Effects Treatment Market Size (2021-2032)
  2. 10.2 Asia Opioid Induced Side Effects Treatment Market Size by Type
  3. 10.2.1 Asia Opioid Induced Side Effects Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Opioid Induced Side Effects Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Opioid Induced Side Effects Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Opioid Induced Side Effects Treatment Market Size by Application
  7. 10.3.1 Asia Opioid Induced Side Effects Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Opioid Induced Side Effects Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Opioid Induced Side Effects Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Opioid Induced Side Effects Treatment Market Size by Country
  11. 10.4.1 Asia Opioid Induced Side Effects Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Opioid Induced Side Effects Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Opioid Induced Side Effects Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Opioid Induced Side Effects Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst